Mariana Abe Vicente Cavagnari

Dr. Mariana Abe Vicente Cavagnari

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2019 in BMC Cancer
Verified
Journal Article
Open access
PDF file
MCMariana Abe Vicente Cavagnari
Mariana Abe Vicente Cavagnari
TSTiago Donizetti Silva
Tiago Donizetti Silva
MPMarco Antonio Haddad Pereira
Marco Antonio Haddad Pereira
LSLuísa Jacques Sauer
Luísa Jacques Sauer
DSDavid Shigueoka
David Shigueoka
NFNora Manoukian Forones
Nora Manoukian Forones
The prognosis of colorectal cancer (CRC) patients can be influenced by genetic mutations and nutritional status. The relationship between these variables is unclear. The objective of the study was to verify the variables involved in the nutritional status and genetic mutations, which correlate with survival of CRC patients. Patients with surgical intervention for tumor resection were evaluated using body mass index, nutritional screening, patient self-produced global subjective assessment, phase angle, and computed tomography to calculate the areas of visceral adipose tissue (VAT) and subcutaneous adipose tissue, and muscle mass for the determination of sarcopenia. Ten gene mutations involved in CRC carcinogenesis were studied (PIK3CA, KRAS, BRAF, EGFR, NRAS, TP53, APC, PTEN, SMAD4, and FBXW7). DNA was extracted from fresh tumor or paraffin tissues. Of the 46 patients, 29 (64.4%) were at nutritional risk and 21 (45.7%) were moderately malnourished. However, there was a high percentage of VAT in 24 (61.5%) and sarcopenia in 19 (48.7%) patients. These variables were associated with a higher risk of mortality. Nutritional risk, moderate or severe malnutrition, phase angle < 5°, VAT < 163.8 cm2 in men and < 80.1 cm2 in women, and sarcopenia were associated with the relative risk of death, with respective hazard ratios/odds ratios and 95% confidence intervals of 8.77 (1.14–67.1), 3.95 (1.11–14.0), 3.79 (1.10–13.1), 3.43 (1.03–11.4), and 3.95 (1.06–14.6). Increased VAT was associated with a lower risk of death, even in patients older than 60 years or those harboring mutated KRAS. Patients with positive indicators for malnutrition or risk of malnutrition had an increased risk of death. No relationship was identified between the presence of mutations and survival.


31 January 2022 in Clinical Nutrition ESPEN
Verified
Journal Article
Closed access
DSDalton Luiz Schiessel
Dalton Luiz Schiessel
AOAmanda Kamitani Góis Orrutéa
Amanda Kamitani Góis Orrutéa
CTCláudia Tramontt
Cláudia Tramontt
MCMariana Abe Vicente Cavagnari
Mariana Abe Vicente Cavagnari
DNDaiana Novello
Daiana Novello
DMDarla Silverio Macedo
Darla Silverio Macedo


29 April 2023 in DEMETRA: Alimentação, Nutrição & Saúde
Verified
Journal Article
Open access
PDF file
MCMariana Abe Vicente Cavagnari
Mariana Abe Vicente Cavagnari
CVCaroline Farias Velho
Caroline Farias Velho
CMCaryna Eurich Mazur
Caryna Eurich Mazur
MPMaria Theresa Melhem Pellissari
Maria Theresa Melhem Pellissari
Introdução: A desnutrição é uma das condições frequentemente observadas em pacientes sob cuidados paliativos, afetando a via de alimentação e impactando na diminuição da ingestão alimentar. O atendimento nutricional permite a identificação das alterações nutricionais, direcionando para terapia nutricional adequada. Objetivo: Analisar a terapia nutricional domiciliar e identificar o estado nutricional em pacientes sob cuidados paliativos no domicílio. Método: Estudo prospectivo, observacional com pacientes do Programa Melhor em Casa, em Guarapuava-PR. Foram avaliados por meio de anamnese, que compreendia diagnóstico clínico, exame físico, caracterização e intercorrências da dieta, SARC-F e avaliação antropométrica. Resultados: Participaram do estudo 24 pacientes, com média de idade 70,2+15,0 anos. Os principais diagnóstico clínicos foram: 45,83% câncer e 45,83% doença neurológica. O baixo peso e a classificação sugestiva de sarcopenia predominaram nos avaliados, sendo 54,17% e 87,5%, respectivamente. A via de acesso para alimentação prevalente foi a oral (45,8%), seguida de 41,7% para sonda nasoenteral; a fórmula mais utiliza foi a hiperproteica. A maioria apresentou sinal da asa quebrada (70,8%), perda da bola de Bichat (66,7%) e perda de massa nos membros superiores e inferiores. O diagnóstico nutricional padronizado mais frequente foi NC-3.2 (perda de peso não intencional), seguido de 41,7% com NI-1.2 (ingestão de energia subótima). Conclusão: Observou-se que a maioria dos pacientes eram idosos, acamados, com doença neurológica e câncer. Em relação ao estado nutricional, a maioria apresentou baixo peso e sinais de desnutrição. O atendimento nutricional com pacientes em cuidados paliativos se faz necessário, pois são pacientes com risco nutricional.

10 May 2022 in Nutrition and Cancer
Verified
Journal Article
Closed access
DSDalton Luiz Schiessel
Dalton Luiz Schiessel
MCMariana Abe Vicente Cavagnari
Mariana Abe Vicente Cavagnari
CMCaryna Eurich Mazur
Caryna Eurich Mazur
AMAngélica Rocha de Freitas Melhem
Angélica Rocha de Freitas Melhem
DGDiogo Dequech Gavarrete
Diogo Dequech Gavarrete
LALindsay Bianca Buzato Antunes
Lindsay Bianca Buzato Antunes
Cancer patients are highly vulnerable to weight loss and malnutrition, before chemotherapy, thus reducing overall survival (OS). The objective was assessing weight loss and OS prognostication in gastric cancer patients at baseline of chemotherapy treatment. Observational retrospective study with patients who were treating in cancer public clinic in Brazil, was evaluated weight loss and cachexia. It was evaluated by sex, BMI, grade system classification (GSC) and stage the OS by Kaplan-Meier method and Cox proportional hazards model. Ninety-two patients, 73.9% were male. At baseline chemotherapy patients have presented 15.3% of body weight loss, 28.3% were malnourished, 86.8% classified witch cachexia, 80.3% were grade 3–4 in GSC and 86.9% at cancer stage 3–4. OS was lower for male (15.9 mo.), malnourished (12.0 mo.), GCS–4 (16.3 mo.) and Stage 4 (13.3 mo.) patients. GSC grade four and BMI classification to underweight comparing obesity are associated with reduced OS, together to male sex and cancer stage 4, have gotten together shown that seems to confer a survival disadvantage to other patients in these parameters too. Cox regression analysis have not shown statistical significance for sex, Initial BMI Class, GSC, cancer stage. Gastric cancer patients at chemotherapy treatment outset present high weight loss, cachexia prevalence and OS reduction.